Novacyt S.A. (Novacyt, the Company or the Group): R&D update

Including launch of two new tests to differentiate between COVID-19 and common winter viruses, and between COVID-19 variants Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international

Related Keywords

France , Foster Mitchell Alex Shaw , Mark Escapeplex , Matthew Johnson Charlie Bouverat , Mark Winterplex , James Mccarthy , Freddie Barnfield James , Graham Mullis , Vadim Alexandre Rob Rees , Novacyt Pathflow , Durgetto Yannick Petit , Numis Securities Limited Joint Broker , Sp Angel Corporate Finance , Company Notified Body , Novacyt Group , Consulting International , Notified Body , Chief Executive Officer , Chief Financial Officer , Nominated Adviser , Johnson Charlie Bouverat , Corporate Finance , Alexandre Rob Rees , Corporate Broking , Securities Limited , Joint Broker , Barnfield James Black , French Listing Sponsor , Novacyt , Company , Group , Update ,